EuroPCR Cancels Annual Meeting Due to COVID-19

May 5, 2020 — The large European interventional cardiology conference EuroPCR has been cancelled due to the contenting containment efforts for COVID-19 (SARS-CoV-2).

"The sanitary and legal environment, and in particular the decisions of the French government barring public gatherings for events exceeding 5,000 participants, have resulted in us cancelling the EuroPCR 2020 Course in Paris as a consequence of the COVID-19 outbreak," stated a letter sent out by EuroPCR today from the EuroPCR Course Directors Andreas Baumbach, Alberto Cremonesi, Jean Fajadet and William Wijns.

They said over the last two to three months, the Paris Course on Revascularization (PCR) mission of sharing knowledge, experience and practice has remained more actively relevant than ever with multiple educational resources freely available on PCRonline.

The organizers of the meeting said they will be working with the program committee to provide a full update on late-breaking trials and other essential educational content. Details of the dates and platform to be used will be announced in the coming weeks.

"We reiterate our heartfelt solidarity to all those affected by the coronavirus across the globe and extend our warmest wishes for good health to you and your patients, colleagues and loved ones," the course directors said in the statement.

For additional information on the status of EuroPCR.